drugset / Trial / NCT03236233

A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786

NCT03236233 ↗

Phase 1 Completed 39 enrolled Pulmocide Ltd
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study investigates the safety, tolerability and pharmacokinetics of single and repeat doses of PC786.

Timeline

Start
2017-06-21
Primary completion
2017-12-15
Completion
2017-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject PC786 Small molecule — Inhaled